Index AR1 - Anticancer Research

More documents

Recommendations

Info

* * * Number 2B Clinical Studies ANTICANCER RESEARCH 28: <strong>Index</strong> (2008) Human Papillomavirus Accounts both for Increased Incidence and Better Prognosis in Tonsillar Cancer. H. DAHLSTRAND, A. NÄSMAN, M. ROMANITAN, D. LINDQUIST, T. RAMQVIST, T. DALIANIS (Stockholm, Sweden)...................................................................................................................................................... Peripheral Blood CD8highCD57+ Lymphocyte Levels May Predict Outcome in Melanoma Patients Treated with Adjuvant Interferon-·. D. CHARACIEJUS, V. PASˇUKONIENE Ø , R. JONUSˇAUSKAITE, N. KAZLAUSKAITE Ø , E. ALEKNAVIČIUS, M. MAURICAS, W. DEN OTTER (Vilnius, Lithuania; Utrecht, The Netherlands)............................................................................................................................................................. The Role of Regulatory T Cells in Malignant Glioma. A.M. SONABEND, C.E. ROLLE, M.S. LESNIAK (Chicago, IL, USA) ........................................................................................................................................................ Comparison of Apolipoprotein D Determination Methods in Breast Cancer. H. SØILAND, I. SKALAND, E.A.M. JANSSEN, E. GUDLAUGSSON, H. KÖRNER, J.E. VARHAUG, J.A. SØREIDE, J.P.A. BAAK (Stavanger; Bergen, Norway; Amsterdam, The Netherlands)...................................................................................... Protein Abundance of Class III Beta-tubulin but Not ¢2-Alpha-Tubulin or Tau is Related to Paclitaxel Response in Carcinomas of Unknown Primary Site. P. SÈVE, T. REIMAN, S. ISAAC, V. TRILLET-LENOIR, L. LAFANÉCHÈRE, M. SAWYER, C. DUMONTET (Lyon; Grenoble, France; Edmonton, AB, Canada) .............. Overexpression of RegIV in Peritoneal Dissemination of Gastric Cancer and Its Potential as A Novel Marker for the Detection of Peritoneal Micrometastasis. K. MIYAGAWA, C. SAKAKURA, S. NAKASHIMA, T. YOSHIKAWA, K. FUKUDA, S. KIN, Y. NAKASE, K. SHIMOMURA, N. OUE, W. YASUI, H. HAYASIZAKI, Y. OKAZAKI, H. YAMAGISHI, A. HAGIWARA, E. OTSUJI (Kyoto; Hiroshima; Yokohama; Saitama, Japan).......................................................................................................................................... Metastatic Embryonal Carcinoma in the Maxillary Gingiva. F. ANGIERO, M. STEFANI (Monza; Milan, Italy) ................................................................................................................................................................................. Chemotherapy Using Hybrid Liposomes along with Induction of Apoptosis. H. ICHIHARA, H. NAGAMI, T. KIYOKAWA, Y. MATSUMOTO, R. UEOKA (Kumamoto Japan) ............................................................... Update on Molecular Pathology in Oral Cancer and Precancer. J. CAMPO-TRAPERO, J. CANO- SÁNCHEZ, B. PALACIOS-SÁNCHEZ, J.J. SÁNCHEZ-GUTIERREZ, M.A. GONZÁLEZ-MOLES, A. BASCONES-MARTÍNEZ (Madrid; Granada, Spain) ............................................................................................. Influence of Resection Volume on Locoregional Recurrence of Breast Cancer after Breast-conserving Surgery. D.U. BOEHM, A. LEBRECHT, T. MALTARIS, M. SCHMIDT, W. SIGGELKOW, S. FISCHER, E. KANDELHART, H. KOELBL (Mainz; Halle, Germany).................................................................................. * Chemotherapy in Gastric Cancer. E. WÖLL, A. DEVRIES, W. EISTERER, M. HEJNA, F. KEIL, H. STEIN, J. ZACHERL, R. GREIL (Zams; Feldkirch; Innsbruck; Vienna; Leoben; Salzbuirg, Austria)............. POLR2F, ATP6V0A1 and PRNP Expression in Colorectal Cancer: New Molecules with Prognostic Significance? A.G. ANTONACOPOULOU, P.D. GRIVAS, L. SKARLAS, M. KALOFONOS, C.D. SCOPA, H.P. KALOFONOS (Rion, Patras, Greece) ............................................................................................... Prospective Phase II Study of Post-surgical Adjuvant Chemo-immunotherapy Using Autologous Dendritic Cells and Activated Killer Cells from Tissue Culture of Tumor-draining Lymph Nodes in Primary Lung Cancer Patients. H. KIMURA, T. IIZASA, A. ISHIKAWA, M. SHINGYOUJI, M. YOSHINO, M. KIMURA, Y. INADA, K. MATSUBAYASHI (Chiba, Japan).............................................................................. 1133 1139 1143 1151 1161 1169 1181 1187 1197 1207 1213 1221 1229 4193
* ANTICANCER RESEARCH 28: <strong>Index</strong> (2008) Neoadjuvant Paclitaxel for Operable Breast Cancer: Multicenter Phase II Trial with Clinical Outcomes. M. KIMURA, M. SANO, M. FUJIMORI, H. NAKAGOMI, T. NEGISHI, Y. YANAGITA, N. SATO (Ota; Isesaki, Gunma; Niigata; Matsumoto, Nagano; Kofu,Yamanashi, Japan) ............................................................... Taxanes and Gemcitabine Doublets in the Management of HER-2 Negative Metastatic Breast Cancer: Towards Optimization of Association and Schedule. G. METRO, A. FABI, M. RUSSILLO, P. PAPALDO, M. DE LAURENTIIS, G. FERRETTI, D. PELLEGRINI, C. NUZZO, V. GRAZIANO, P. VICI, M. INTRONA, A. FELICI, F. COGNETTI, P. CARLINI (Rome; Naples, Italy)..................................................... Adjuvant Tamoxifen in Breast Cancer Patients Affects the Endometrium by Time, an Effect Remaining Years after End of Treatment and Results in an Increased Frequency of Endometrial Carcinoma. B. LINDAHL, E. ANDOLF, C. INGVAR, J. RANSTAM, R. WILLÉN (Lund; Stockholm; Uppsala, Sweden)................................. Development of Cancer in Patients with Primary Immunodeficiencies. K. SALAVOURA, A. KOLIALEXI, G. TSANGARIS, A. MAVROU (Athens, Greece)................................................................................................... Gender-specific Association between Polymorphism of Vascular Endothelial Growth Factor (VEGF 936 C>T) Gene and Colon Cancer in Korea. S.J. BAE, J.W. KIM, H. KANG, S.G. HWANG, D. OH, N.K. KIM (Seongnam, South Korea) .................................................................................................................................... Prognostic Significance of the Local Expression of Interleukin-12 in Patients with Advanced Gastric Cancer. N. NAGASHIMA, Y. NAKAYAMA, Y. INOUE, J. NAGATA, K. MATSUMOTO, N. MINAGAWA, T. KATSUKI, K. SHIBAO, K. HIRATA, T. SAKO, T. HAMADA, N. NAGATA (Kita-Kyushu; Kurate-machi, Japan)............................................................................................................................................................................... Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Squamous Cell Carcinoma. C. BARONE, R. GRILLO, D. DONGIOVANNI, N. BIROCCO, M. RAMPINO, M.G. RUO REDDA, E. GARIBALDI, F. MUNOZ, G. PECORARI, A. CAVALOT, P. GARZINODEMO, L. BUFFONI, L. CIUFFREDA, U. RICARDI, G. CORTESINA, C. GIORDANO, M. FASOLIS, S. BERRONE, O. BERTETTO, M. SCHENA (Torino, Italy)............................................................................................................................. Weekly 24-hour Infusional 5-Fluorouracil as Initial Treatment for Advanced Gastric Cancer with Acute Disseminated Intravascular Coagulation. T.-C. HUANG, K.-H. YEH, A.-L. CHENG, C.-H. HSU (Taipei; Yun-lin, Taiwan, ROC) .................................................................................................................................................. Squamous Cell Lung Carcinoma Metastatic to the Breast. W. HSU, S.-M.S.-CHEN, J.-L. WANG, C.-C. HUANG, S.-F. KO (Kaohsiung, Taiwan, ROC) ........................................................................................................ * Present Treatment and Future Expectations in Advanced Pancreatic Cancer. G.P. STATHOPOULOS, N. ANDROULAKIS, J. SOUGLAKOS, J. STATHOPOULOS, V. GEORGOULIAS (Athens; Heraklion, Greece)............................................................................................................................................................................. Impact of Palliative Gastrectomy in Patients with Incurable Advanced Gastric Cancer. C. KUNISAKI, H. MAKINO, R. TAKAGAWA, T. OSHIMA, Y. NAGANO, S. FUJII, H. AKIYAMA, Y. OTSUKA, H.A. ONO, T. KOSAKA, Y. ICHIKAWA, H. SHIMADA (Yokohama, Japan) .......................................................... Association of the Myeloperoxidase Polymorphism with the Risk of Gastric Cancer. P.-I HSU, J.-J. JWO, C.-L. YANG, P.-N. HSU, H.-B. YANG, K.-H. LAI, I.-S. CHEN, S.-K. CHUAH, D.-C. WU, A. CHEN (Kaohsiung; Taipei; Hsin-chu, Taiwan, ROC) ............................................................................................................ Disease Presentation and Outcome in Young Patients (
Page 1 and 2: ANTICANCER RESEARCH International J
Page 3 and 4: Editorial Board ANTICANCER RESEARCH
Page 5 and 6: ANTICANCER RESEARCH 28: Index (2008
Page 7 and 8: Department of Health, Executive Yua
Page 9 and 10: National R&D Program for Cancer Con
Page 11 and 12: Number 1A Experimental Studies ANTI
Page 15 and 16: * ANTICANCER RESEARCH 28: Index (20
Page 17 and 18: Amelanotic Metastasis of Melanoma M
Page 21: ANTICANCER RESEARCH 28: Index (2008
Page 25 and 26: Detection of Oncogenic DNA Viruses
Page 27 and 28: Gross Thymic Extract, Thymax, Induc
Page 31 and 32: * Number 4A Special Issue on Prosta
Page 37 and 38: Adjuvant Treatment for Elderly Pati
Page 45 and 46: * * ANTICANCER RESEARCH 28: Index (
Page 47 and 48: Number 6B Clinical Studies ANTICANC
Page 49 and 50: Abstracts of the 14th International
Page 51 and 52: Aggrecan, versican, decorin, Wester
Page 53 and 54: Apoptosis, inotodiol, lanostane tri
Page 55 and 56: Bone metastases, bisphosphonates, z
Page 57 and 58: Capecitabine, colorectal cancer, ir
Page 59 and 60: Chemoresistance, cancer of unknown
Page 61 and 62: Colorectal adenoma, Cox-2 polymorph
Page 63 and 64: Cytotoxicity, ferrocene, β-diketon
Page 65 and 66: Electrochemiluminescence immunoassa
Page 67 and 68: Ferrocene, β-diketone, cytotoxicit
Page 69 and 70: Genistein, soy extract, MDA-MB-231
Page 71 and 72: Histone deacetylase inhibitor, vita
Page 73 and 74:
Infusion, 5-fluorouracil, arterial,
Page 75 and 76:
Liver metastasis, pioglitazone, col
Page 77 and 78:
Melphalan, hyperthermia, apoptosis,
Page 79 and 80:
Mucin, adenocarcinoma, metastatic b
Page 81 and 82:
Oesophageal cancer, carboplatin, el
Page 83 and 84:
P53, syndecan-1, tenascin-C, TATI,
Page 85 and 86:
Plumbagin, apoptosis, pro-apoptotic
Page 87 and 88:
ProGRP, small cell lung cancer, NSE
Page 89 and 90:
RA-resistance, leukemia cells, reti
Page 91 and 92:
S-1, cisplatin, advanced pancreatic
Page 93 and 94:
Sonic hedgehog, breast cancer, estr
Page 95 and 96:
Thrombosis, gynecological cancer, c
Page 97 and 98:
Type of cell death, β-cyclodextrin
Page 99 and 100:
Authors Index (Figures refer to pag
Page 101 and 102:
Cho S-H, 2649 Choi MS, 3777 Chorti
Page 103 and 104:
Giuliani L, 1405 Goda T, 2343 Goess
Page 105 and 106:
Katano M, 731, 2401 Katayama K, 847
Page 107 and 108:
Mahajan A, 741 Maiti A, 3705 Majka
Page 109 and 110:
Onogawa T, 2669 Onouchi S, 145 Onoz
Page 111 and 112:
Scotti M, 1951 Sculli CM, 3055 Seco
Page 113 and 114:
Usami M, 3913 Ushijima R, 601 Usui
Page 115 and 116:
Errata ANTICANCER RESEARCH 28: Inde
Page 117 and 118:
Medicherla et al: TGF-‚ Inhibitor
Page 119 and 120:
Volume 28 (2008), No 2A, page 1072:
Page 121:
Publication Data: ANTICANCER RESEAR
show all

Index AR1 - Anticancer Research

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?